<?xml version="1.0" encoding="ISO-8859-1" ?>
		<rss version="2.0"> 
		<channel>
			<!--<title>UMHS News</title> --> 
			
			<title>Infectious Diseases</title>
			<description>News from the University of Michigan Health System</description> 
			<language>en-us</language> 
			<link>http://www2.med.umich.edu/prmc/media/relarch.cfm</link> 
			<copyright>© 2008, The University of Michigan</copyright> 
			<managingEditor>cpaxton@med.umich.edu</managingEditor> 
			<webMaster>cpaxton@med.umich.edu</webMaster> 
			<lastBuildDate>Mon, 09 Jun 2008 14:41:26  02:06:26  EST</lastBuildDate>
				<image>
				<title>University of Michigan Health System</title>
				<url>http://www.med.umich.edu/1images/2logo.gif</url>
				<link>http://www.med.umich.edu</link>
				</image>
		
			
			<item>
				<title>Taming the anthrax threat</title>        
				<description>U-M scientists have done the first complete analysis of genes active in the anthrax microbe as it invades the lungs.  The work should pave the way for better drugs in the event of an attack. </description>
				<link>http://www.med.umich.edu/opm/newspage/2007/chink.htm</link>
				<pubDate>Tue, 31 Jul 2007 12:07:00 EST</pubDate>
				<keywords>Drugs and medications, Medical School, </keywords>
				<category>All</category>
				<category>Infectious Diseases</category>
			</item>
		
			
			<item>
				<title>Nanoemulsion vaccines effective against two new targets</title>        
				<description>A novel technique for vaccinating against a variety of infectious diseases – using an oil-based emulsion placed in the nose, rather than needles – has proved able to produce a strong immune response against smallpox and HIV in two new studies.
</description>
				<link>http://www.med.umich.edu/opm/newspage/2008/nanomulsion.htm</link>
				<pubDate>Tue, 26 Feb 2008 12:02:00 EST</pubDate>
				<keywords>Infectious Disease, Nanotechnology, </keywords>
				<category>All</category>
				<category>Infectious Diseases</category>
			</item>
		
			
			<item>
				<title>U-M study: Identifying cirrhosis with better accuracy </title>        
				<description>A U-M-led study of patients with advanced chronic hepatitis C revealed that a 3-variable model of serum fibrosis markers, including serum HA, TIMP-1 and platelet count, could identify cirrhosis with better accuracy than other published models. These findings are in the March issue of Hepatology.</description>
				<link>http://www.med.umich.edu/opm/newspage/2008/hepc.htm</link>
				<pubDate>Mon, 03 Mar 2008 12:03:00 EST</pubDate>
				<keywords>Gastrointestinal, </keywords>
				<category>All</category>
				<category>Infectious Diseases</category>
			</item>
		
			</channel>
			</rss>
		
